Larger lesions may be associated with typical mammographic appearances although many smaller lesions are incidental microscopic findings on benign breast biopsies or therapeutic excision specimens for breast cancer. The characteristic microscopic appearance is that of a stellate abnormality with slender, radially arranged bands containing ductal structures surrounding a central fibroelastotic core.
Mammographic features include an asymmetric density or distortion with spicules radiating from a central lucency. Typically, appearances differ depending on the radiological projection. Radial scars and complex sclerosing lesions are seen as the same clinical entity [1] with the latter term used for lesions 10mm or greater in diameter [2] .
Clinical Significance
The main clinical significance of radial scars is their possible association with the development of breast cancer. Several observations have led to this suggestion including similar mammographic and histological appearances [3] [4] [5] [6] [7] ; the finding of carcinomas in radial scars [1, 5, [8] [9] [10] [11] [12] [13] [14] [15] [16] ; and the association with other forms of benign proliferative disease known to predispose to the development of breast cancer [17] [18] [19] [20] .
Various studies have investigated the possible association between radial scars and breast cancer, with conflicting results. There is a trend towards the presence of radial scars being an independent risk factor for the development of breast cancer, but only a minority of studies have reached significance [21] . Whilst it is becoming clear that the presence of a RS/CSL is associated with an increased risk of M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT development of carcinoma, it is not clear whether these lesions act simply as a marker of increased risk, whether they independently increase the risk or whether they are themselves premalignant.
Size of RS/CSL
The effect of lesion size has not yet been fully evaluated. A number of reports suggest that larger RS/CSLs are more often associated with cancers [15, 22] . It has been proposed that lesions of greater than 6-7mm [22] and in particular more than 10mm [15] are the most likely to be associated with carcinomas. Other studies have also shown a trend towards larger RS/CSLs having a greater risk of developing breast cancer [17, 21, 23] but none have reached statistical significance. Whilst there are some data published on the associations of smaller radial scars (median 4.0mm [17, 21] , majority <5.0mm [23] ) there is little information available on the long term follow-up of larger radial scars in studies of significant size.
Aims
This study investigates the long term outcome in a cohort of women with a history of RS/CSL in a benign excision biopsy specimen. It aims to analyse the rate of development of subsequent breast cancer with respect to lesion size and to compare to the rate of breast cancer development to that expected in an age matched UK population.
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Patients and Methods
Patients
Data were collected from women with a histological diagnosis of RS/CSL at a single institution over a 20year period, 1989 to 2009. Patients with a simultaneous breast malignancy were excluded from the study leaving 164 subjects.
Methods
For the purpose of this study, breast cancer was defined as any invasive carcinoma or carcinoma-in-situ, an established practice in similar reports. Data were recorded on the patients' age at diagnosis, past history of breast disease and any previous breast imaging. Details of the procedures performed, size and number of RS/CSLs and presence of any other associated pathology such as atypical hyperplasia were noted. The database was updated with details of follow-up events and any subsequent mammogram results. The total length of follow up was then recorded in months from initial diagnosis to the most recent episode.
From the initial cohort of 164 patients, those with atypical ductal hyperplasia (ADH) or lobular carcinoma-in-situ (LCIS) at the time of diagnosis were excluded.
The rate of developing subsequent cancer was calculated and compared to nationally available data for expected rates of breast cancer in women of comparable age.
Groups
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Subjects were divided into two groups depending on whether the lesion was < 10mm (RS) or ≥ 10mm (CSL). Groups were compared for age at diagnosis, length of follow up, number of RS/CSL and proportion of patients developing subsequent cancer. 110 had long term follow up data available with a range of 9-216 months (median 68 months).
Statistical Methods
Rate of subsequent cancer
Five patients developed subsequent carcinoma giving an incidence of breast cancer development of 0.84% per year (95% confidence interval 0.28% -1.92%). The equivalent risk in the UK population of a comparable age is 0.32% [24] giving a relative risk of 2.63 (95% confidence interval 0.86 -6.0). Of the 5 patients developing subsequent cancer, three were in the ipsilateral breast and two were in the contralateral breast.
Groups
After exclusion of three patients whose size of lesion was unknown, the study population was divided into RS (n=45) and CSL (n=101) groups according to the size of the lesion. The mean ages in the groups 
Rate of subsequent cancer by group
There were two subsequent cancers in the RS group and three subsequent cancers in the CSL group, P= 0.64. Two cancers affected the contralateral breast and three were in the ipsilateral breast.
Within the RS group, one patient with subsequent cancer presented with a lump and one was identified through routine screening mammography. Cancers were of invasive ductal and tubular types.
Mastectomy was performed for the invasive ductal carcinoma, whereas the tubular carcinoma was treated with a wide local excision and radiotherapy.
In the CSL group, one patient presented with a symptomatic lump, one through a routine follow up appointment and one was identified through routine screening mammography. Two were invasive ductal carcinomas and one a tubular carcinoma. The ductal carcinomas were treated by mastectomy and the tubular carcinoma by wide local excision. All received radiotherapy.
Discussion
Background
A RS/CSL may be an incidental finding at biopsy in asymptomatic patients. The lesions are also increasingly identified through population based mammographic screening programmes and confirmed M A N U S C R I P T
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histologically when excised. RS/CSLs have been associated with cancer at the time of diagnosis and an increased risk of subsequent development of breast cancer. Whilst some studies have suggested it may be safe in selected patients to manage these lesions conservatively following satisfactory core biopsies [25] [26] [27] [28] , most authors advise excising all lesions in order to exclude any coexisting carcinoma [1, 5, 8, 9, 15, [29] [30] [31] [32] . Recently the Royal College of Radiologists have revised their guidelines for assessment in the screening programme. The have indicated that where available, vacuum biopsy excision is an acceptable alternative to surgical excision in cases with no atypia, though this practice is not yet widespread in the UK.
Association with cancer
It is not currently known whether RS/CSLs only represent a marker for cancer or are in themselves premalignant. It is difficult to study the natural history of RS/CSLs given that they are quite rare and usually excised. The finding of cancers in association with these lesions has prompted the theory that they represent a premalignant condition [5, [8] [9] [10] [11] [12] [13] [14] [15] . In contrast, autopsy studies have commonly identified radial scars but they report no difference in the frequency of radial scars identified between women with and without breast malignancy [33, 34] .
Following excision, RS/CSLs have been associated with an increased risk of developing cancer [17, 21, 23 ]. This has also been described in other forms of benign proliferative disease [18, 19] . RS/CSLs are also known to be more common in the presence of benign proliferative disease and therefore, the question has been raised whether it is the associated disease which gives rise to a greater risk of cancer or the RS/CSLs themselves.
Jacobs et al stated that radial scars are an independent risk factor for the development of breast cancer [21] . In contrast to this, Berg et al concluded that these lesions were not independent risk factors and M A N U S C R I P T
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that any increased risk was attributable to associated proliferative disease such as atypical hyperplasia [23] .
When RS/CSLs have been stated to increase the risk of cancer development, contralateral and ipsilateral sides have been affected equally [21] . This suggests that any predisposition to breast cancer may be a generalised phenomenon affecting all breast tissue rather than a localised consequence of the RS/CSL.
Our study suggests a trend toward higher rates of cancer than in the age-matched UK population even when atypical proliferative diseases are excluded. As with similar studies [17, 23] , this does not reach statistical significance. This study therefore gives no evidence to support the idea that RS/CSLs are independent risk factors. It is possible that the study population is not large enough to demonstrate this statistically, a commonly identified problem in previous similar studies. Large patient numbers are required to increase the power of future studies. Our study excludes RS/CSL associated with ADH/LCIS, but it may be that ADH/LCIS association is part of the natural history by which RS/CSL increase the likelihood of malignancy, thus our study would underestimate the risk of carcinoma. In addition, longer follow up lengths are required as RS/CSLs are frequently identified through the incident mammographic screening round soon after the age of 50 years whereas the incidence of breast cancers continues to increase with increasing age, possibly representing a significant time lag.
Size of RS/CSL
It has also been suggested that the size of RS/CSL may be important, with larger lesions more likely to have malignant potential [15, 22] . There are few data available in significant numbers on lesions greater than 10mm in diameter.
Manfrin et al analysed follow up in 117 cases of RS/CSL with a mean diameter of 10.1mm [15] . They Manfrin et al found that patients with coincident cancer generally had larger RS/CSL and suggest that radial scars and complex sclerosing lesions represent a natural model of carcinogenesis from proliferative disease, through atypia to insitu and invasive carcinoma. However, the patients in the cancer/atypical hyperplasia groups were older than those in the group without cancer. It is known that both RS/CSLs [17, 23] and breast cancer are more common with increasing age, therefore, the association of breast cancer and larger RS/CSLs may simply reflect age related changes.
Our series contains a significant proportion of larger lesions with follow up lengths up to 18 years in subjects without previous cancer. There were no differences between the RS and CSL groups in terms of age, length of follow up or number of radial scars per subject. RS and CSL groups did not differ in the proportion of patients developing subsequent cancer giving no support to the theory that lesions greater than 10mm in diameter (CSL) are associated with a greater risk of developing cancer compared with lesions below 10mm (RS).
Conclusion
Given the rate of subsequent malignancy in women who have a RS/CSL excised, no additional follow up 
